Equity Research, Broker Reports, and media content on Allergy Therapeutics plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Allergy Therapeutics plc

Company Profile

  • Personnel:
  • Manuel Llobet , CEO
  • Nicolas Wykeman, Finance Director

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics plc. We currently have 300 research reports from 9 professional analysts.

Date Source Announcement
01Jul22 07:00 RNS Allergy Therapeutics - Allergy Therapeutics at EAACI Congress 2022
26May22 07:00 RNS Allergy Therapeutics - Nick Wykeman to step down as CFO
23May22 07:00 RNS Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
25Apr22 07:00 RNS Allergy Therapeutics - Allergy Therapeutics shares data at WAO-BSACI
08Mar22 07:00 RNS Allergy Therapeutics - Allergy Therapeutics at Cowen Health Conference
07Mar22 07:00 RNS Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
03Mar22 07:00 RNS Allergy Therapeutics - Allergy Therapeutics plc – Interim Results
  • Frequency of research reports

     

  • Research reports on

    Allergy Therapeutics plc

  • Providers covering

    Allergy Therapeutics plc